sonar-pro
Permits stability data submission for pharmaceutical products at 25째C/60% relative humidity (RH) when supported by accelerated stability studies.
{
  "id": "efd3a071-c8f7-434c-a6f3-1224a7e5075b",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"answer\":\"YES\",\"note\":\"Malaysia allows submission of stability data at 25째C/60% RH, provided this is supported by accelerated (40째C/75% RH) stability studies, and this is in line with both the Malaysian Drug Registration Guidance Document and ASEAN Common Technical Requirements[1][5]. The submitted data should include long-term (25째C/60% RH) and accelerated data from batches manufactured at the proposed site; if deficiencies are found at accelerated conditions, the shelf life is based on long-term data[1][5]. Local guidelines primarily follow ICH/ASEAN standards, which permit this approach.\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755744017,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 129,
    "prompt_tokens": 31,
    "total_tokens": 160,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.002,
      "request_cost": 0.006,
      "total_cost": 0.008
    }
  },
  "citations": [
    "https://www.npra.gov.my/easyarticles/images/users/1153/drgd_appendices/APPENDIX-3-Guidelines-on-Registration-of-New-Drug-Products.pdf",
    "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
    "https://credevo.com/articles/2022/10/05/drug-registration-in-malaysia-regulatory-process-requirements/",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
    "https://asean.org/wp-content/uploads/2021/08/ASEAN-Common-Technical-Requirements-ACTR.pdf"
  ],
  "search_results": [
    {
      "title": "APPENDIX-3-Guidelines-on-Registration-of-New-Drug- ...",
      "url": "https://www.npra.gov.my/easyarticles/images/users/1153/drgd_appendices/APPENDIX-3-Guidelines-on-Registration-of-New-Drug-Products.pdf",
      "date": null,
      "last_updated": "2025-08-14"
    },
    {
      "title": "[PDF] Annex 2 Stability testing of active pharmaceutical ingredients and ...",
      "url": "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
      "date": null,
      "last_updated": "2025-03-27"
    },
    {
      "title": "Regulatory For Drug Registration In Malaysia",
      "url": "https://credevo.com/articles/2022/10/05/drug-registration-in-malaysia-regulatory-process-requirements/",
      "date": "2022-10-05",
      "last_updated": "2025-08-18"
    },
    {
      "title": "[PDF] Q 1 A (R2) Stability Testing of new Drug Substances and Products",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "ASEAN Common Technical Requirements (ACTR)",
      "url": "https://asean.org/wp-content/uploads/2021/08/ASEAN-Common-Technical-Requirements-ACTR.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    }
  ]
}